Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Comparative Effectiveness Research
|
February 17, 2023
Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
Nanhua Zhang, Chunyan Liu, Steven J Steiner, et al.
Inflammatory Bowel Diseases
|
September 1, 2022
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity
Jeremy Adler, Richard B Colletti, Lenore Noonan, et al.
Pediatrics
|
March 14, 2012
Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
Wallace V Crandall, Peter A Margolis, Michael D Kappelman, et al.
Inflammatory Bowel Diseases
|
September 3, 2010
Short pediatric Crohn's disease activity index for quality improvement and observational research
Michael D Kappelman, Wallace V Crandall, Richard B Colletti, et al.
Inflammatory Bowel Diseases
|
December 29, 2021
Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease
Jeremy Adler, Sally J Eder, Acham Gebremariam, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2007
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
, , Athos Bousvaros, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 2, 2026
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study
Steven J Steiner, Jeremy Adler, Shehzad A Saeed, et al.
Archives of Internal Medicine
|
February 13, 2003
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study
Alessio Fasano, Irene Berti, Tania Gerarduzzi, et al.
Inflammatory Bowel Diseases
|
September 13, 2011
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease
Millie D Long, Wallace V Crandall, Ian H Leibowitz, et al.
Gastroenterology
|
February 15, 2017
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
Jeffrey S Hyams, Marla C Dubinsky, Robert N Baldassano, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Comparative Effectiveness Research
|
February 17, 2023
Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
Nanhua Zhang, Chunyan Liu, Steven J Steiner, et al.
Inflammatory Bowel Diseases
|
September 1, 2022
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity
Jeremy Adler, Richard B Colletti, Lenore Noonan, et al.
Pediatrics
|
March 14, 2012
Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
Wallace V Crandall, Peter A Margolis, Michael D Kappelman, et al.
Inflammatory Bowel Diseases
|
September 3, 2010
Short pediatric Crohn's disease activity index for quality improvement and observational research
Michael D Kappelman, Wallace V Crandall, Richard B Colletti, et al.
Inflammatory Bowel Diseases
|
December 29, 2021
Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease
Jeremy Adler, Sally J Eder, Acham Gebremariam, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2007
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
, , Athos Bousvaros, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 2, 2026
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study
Steven J Steiner, Jeremy Adler, Shehzad A Saeed, et al.
Archives of Internal Medicine
|
February 13, 2003
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study
Alessio Fasano, Irene Berti, Tania Gerarduzzi, et al.
Inflammatory Bowel Diseases
|
September 13, 2011
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease
Millie D Long, Wallace V Crandall, Ian H Leibowitz, et al.
Gastroenterology
|
February 15, 2017
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
Jeffrey S Hyams, Marla C Dubinsky, Robert N Baldassano, et al.
Page
of 5